A significant positive correlation exists between CD169 expression in TDLN macrophages and CD8+ T cell infiltration in esophageal cancer, gastric cancer, and colorectal cancer along with improved overall survival and enhanced anti-cancer immune responses [168,169,170,171]. This evidence concerns the gene SIGLEC1 and cancer.